Roivant Sciences Ltd. buy BiotechBee
Start price
24.06.23
/
60%
€9.00
Target price
31.12.25
€16.00
Performance (%)
25.44%
End price
14.12.24
€11.29
Summary
This prediction ended on 14.12.24 with a price of €11.29. The prediction had a final performance of 25.44%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Roivant Sciences Ltd. | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
According to BiotechBee what are the pros and cons of Roivant Sciences Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Roivant Sciences Ltd. diskutieren
Buy mit Kursziel 16,0
In the thread Trading Roivant Sciences Ltd.
Buy beendet

